NASDAQ:APRE | Cash Flow Statement | Aprea Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.59M
2026-03-31-$3.29M$5,428.00-$2.76M$34.62M
2025-12-31-$2.46M$5,429.00-$2.96M$3.84M
2025-09-30-$2.97M
2025-06-30-$3.24M
2025-03-31-$3.93M$5,429.00-$3.63M$55,849.00
2024-12-31-$2.89M$5,428.00-$3.51M$0.00$0.00$134,405.00
2024-09-30-$3.78M
2024-06-30-$3.47M
2024-03-31-$2.81M$6,157.00-$3.94M$7,978.00-$7,978.00$14.71M
2023-12-31-$3.44M$4,986.00-$3.74M$7,150.00-$7,150.00$0.00
2023-09-30-$3.2M
2023-06-30-$3.26M
2023-03-31-$4.38M$410.00-$2.98M$5.14M
2022-12-31-$2.44M-$2,385.00-$4.02M$98,526.00
2022-09-30-$4.02M
2022-06-30-$98.26M
2022-03-31-$7.94M$2,942.00-$5.5M
2021-12-31-$7.76M$2,969.00-$10.18M$1.66M
2021-09-30-$9.45M
2021-06-30-$10.25M
2021-03-31-$9.67M$3,588.00-$11.52M
2020-12-31-$15.39M$16,657.00-$13.2M$16,290.00-$16,290.00$0.00
2020-09-30-$12.32M
2020-06-30-$16.37M
2020-03-31-$9.4M$3,812.00-$7.54M$12,165.00-$12,165.00$29,523.00
2019-12-31-$13.07M$2,273.00-$14.74M$14,466.00-$14,466.00$91.2M
2019-09-30-$6.25M
2019-06-30-$5.26M
2019-03-31-$3.48M$2,141.00-$4.2M$5.43M
2018-12-31-$4.68M$1,795.00-$3.85M-$804.00$804.00$56.37M
2018-09-30-$3.14M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$12.6M$21,715.00-$12.89M$4.64M
2024-12-31-$12.96M$22,318.00-$13.56M$15,478.00-$15,478.00$14.82M
2023-12-31-$14.29M$7,052.00-$12.18M$93,093.00-$93,093.00$5.14M
2022-12-31-$112.66M$4,403.00-$25.01M$682,973.00
2021-12-31-$37.13M$12,829.00-$37.69M$1.75M
2020-12-31-$53.48M$28,834.00-$41.8M$25,709.00-$25,709.00$150,949.00
2019-12-31-$28.06M$11,126.00-$26.71M$30,901.00-$30,901.00$92.58M
2018-12-31-$15.53M$8,316.00-$15.25M$3,702.00-$3,702.00$56.37M
2017-12-31-$15.19M$7,932.00-$14M$23.34M